Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Fomento Económico Mexicano
FMX
$42.8B
| $4.36M | ﹤0.01% |
40,503
-96,481
| -70% | -$11.3M |
|
1602
Terreno Realty
TRNO
$7.58B
| $4.36M | ﹤0.01% |
73,600
-47,104
| -39% | -$2.71M |
|
1603
CALL
Cytokinetics
CYTK
$10.4B
| $4.33M | ﹤0.01% |
80,000
+52,000
| +186% | +$3.14M |
|
1604
Lyft
LYFT
$6.22B
| $4.33M | ﹤0.01% |
307,347
+137,488
| +81% | +$2.23M |
|
1605
CALL
Baidu
BIDU
$38.3B
| $4.32M | ﹤0.01% |
50,000
| – | – |
|
1606
Olin
OLN
$2.12B
| $4.31M | ﹤0.01% |
91,428
-84,237
| -48% | -$4.51M |
|
|
AXNX
1607
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.31M | ﹤0.01% |
64,111
-2,024
| -3% | -$136K |
|
1608
Goodyear
GT
$2.02B
| $4.28M | ﹤0.01% |
377,304
-241,135
| -39% | -$2.95M |
|
|
ONC
1609
CALL
BeOne Medicines Ltd
ONC
$32.6B
| $4.28M | ﹤0.01% |
+30,000
| New | +$4.62M |
|
1610
Cal-Maine
CALM
$4.08B
| $4.27M | ﹤0.01% |
69,827
-14,067
| -17% | -$835K |
|
1611
Madrigal Pharmaceuticals
MDGL
$11.1B
| $4.26M | ﹤0.01% |
15,196
-10,027
| -40% | -$2.39M |
|
1612
Visteon
VC
$2.82B
| $4.25M | ﹤0.01% |
39,823
-20,481
| -34% | -$2.26M |
|
1613
CALL
Viking Therapeutics
VKTX
$3.8B
| $4.24M | ﹤0.01% |
80,000
+32,300
| +68% | +$2.12M |
|
1614
UL Solutions
ULS
$18.4B
| $4.22M | ﹤0.01% |
+100,000
| New | +$3.79M |
|
1615
OceanFirst Financial
OCFC
$1.71B
| $4.21M | ﹤0.01% |
264,976
-48,611
| -16% | -$735K |
|
1616
CALL
KKR & Co
KKR
$95.7B
| $4.21M | ﹤0.01% |
40,000
| – | – |
|
1617
Fabrinet
FN
$16.3B
| $4.18M | ﹤0.01% |
17,086
-20,166
| -54% | -$4.28M |
|
1618
AeroVironment
AVAV
$8.06B
| $4.18M | ﹤0.01% |
22,927
-9,381
| -29% | -$1.69M |
|
1619
Corbus Pharmaceuticals
CRBP
$165M
| $4.15M | ﹤0.01% |
91,728
-93,420
| -50% | -$3.93M |
|
1620
Beazer Homes USA
BZH
$901M
| $4.15M | ﹤0.01% |
150,989
+12,364
| +9% | +$351K |
|
1621
H.B. Fuller
FUL
$3.07B
| $4.15M | ﹤0.01% |
53,870
+3,108
| +6% | +$242K |
|
1622
Transocean
RIG
$5.7B
| $4.14M | ﹤0.01% |
774,243
+211,618
| +38% | +$1.22M |
|
1623
CALL
FTAI Aviation
FTAI
$23.1B
| $4.13M | ﹤0.01% |
40,000
-10,000
| -20% | -$795K |
|
|
AZEK
1624
DELISTED
The AZEK Co
AZEK
| $4.12M | ﹤0.01% |
97,769
-43,199
| -31% | -$2M |
|
1625
Ingredion
INGR
$6.33B
| $4.11M | ﹤0.01% |
35,859
-30,116
| -46% | -$3.48M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.